The MEN1 gene and associated diseases: An update

Endocrine Pathology

Volumn 12, Issue 3, 2001, Pages 259-273

  Tsukada, Toshihiko ^a   Yamaguchi, Ken ^a   Kameya, Toru ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

DNA test; Germline; Hyperparathyroidism; MEN1; Menin; Multiple endocrine neoplasia type 1; Mutation; Tumor suppressor gene

Indexed keywords

METHIONINE;

AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOMAL LOCALIZATION; CLINICAL FEATURE; DISEASE PREDISPOSITION; DNA DETERMINATION; FAMILIAL CANCER; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HYPERPARATHYROIDISM; MISSENSE MUTATION; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 0035693351     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:12:3:259     Document Type: Review

References (107)

1. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1
2. Recent advances in multiple endocrine neoplasia syndromes
3. Clinical studies of multiple endocrine neoplasia type 1 (MEN1)
4. Genetic aspects of adenomatosis of endocrine glands
5. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1
6. Surgical versus medical management of multiple endocrine neoplasia (MEN) type I
7. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene
8. Localization of the multiple endocrine neoplasia type I (MEN1) gene based on tumor loss of heterozygosity analysis
9. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
10. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11
11. Positional cloning of the gene for multiple endocrine neoplasia-type 1
12. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene
13. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors
14. Loss of heterozygosity at 11q13: Analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1
15. An unusual kindred of the multiple endocrine neoplasia type 1 (MEN1) in Japanese
16. Germline mutations of the MEN 1 gene in familial multiple endocrine neoplasia type 1 and related states
17. MEN 1 gene mutations in 12 MEN1 families and their associated tumors
18. Characterization of mutations in patients with multiple endocrine neoplasia type 1
19. Identification of MEN 1 gene mutations in families with MEN 1 and related disorders
20. Phenotype and phenocopy: The relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1)
21. A new mutation of the MEN 1 gene in an Italian kindred with multiple endocrine neoplasia type 1
22. Screening for MEN 1 mutations in patients with atypical endocrine neoplasia
23. Identification of MEN 1 gene mutations in sporadic carcinoid tumors of the lung
24. Germline mutations in the MEN1 gene: Creation of a new splice acceptor site and insertion of 7 intron nucleotides into the mRNA
25. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders
26. MEN 1 gene mutation analysis of sporadic adrenocortical lesions
27. Mutations and allelic deletions of the MEN 1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms
28. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1)
29. Clinical features of multiple endocrine neoplasia type 1 (MEN1) phenocopy without germline MEN1 gene mutations: Analysis of 20 Japanese sporadic cases with MEN1
30. Novel germline mutations of the MEN1 gene in Japanese patients with multiple endocrine neoplasia type 1
31. Somatic mutation of the MEN1 gene in parathyroid tumours
32. Novel deletional mutation of the MEN1 gene in a kindred with multiple endocrine neoplasia type 1
33. A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1
34. A novel splicing mutation (894-9 G → A) of the MEN1 gene responsible for multiple endocrine neoplasia type 1
35. Multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors, and MENIN
36. Molecular pathology of multiple endocrine neoplasia type I: Two novel germline mutations and updated classification of mutations affecting MEN1 gene
37. Menin mutations in patients with multiple endocrine neoplasia type 1
38. Menin mutations in MEN1 patients
39. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1
40. Germline mutations in the multiple endocrine neoplasia type 1 gene: Evidence for frequent splicing defects
41. Mutation analysis of the MEN1 gene in Belgian patients with multiple endocrine neoplasia type 1 and related diseases
42. Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1
43. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families
44. Analysis of the MEN1 gene in sporadic pituitary adenomas
45. Germline mutations of the MEN1 gene in Japanese kindred with multiple endocrine neoplasia type 1
46. Pituitary macroadenoma in a 5-year-old: An early expression of multiple endocrine neoplasia type 1
47. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese
48. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism
49. An intronic splicing mutation of the MEN1 gene
50. Screening of the MEN1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors
51. Multiple endocrine neoplasia type 1 (MEN1): Clinical heterogeneity in a large family with a nonsense mutation in the MEN1 gene (Trp471Stop)
52. Hereditary cancer: Two hits revisited
53. Alterations of the MEN1 gene in sporadic parathyroid tumors
54. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas
55. Perivascular cells harboring multiple endocrine neoplasia type 1 alterations are neoplastic cells in angiofibromas
56. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas
57. Mutations of the MEN1 tumor suppressor gene in pituitary tumors
58. Menin, the product of the MEN1 gene, is a nuclear protein
59. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms
60. Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1
61. Proliferation-associated expression of the MEN1 gene as revealed by in situ hybridization: Possible role of the menin as a negative regulator of cell proliferation under DNA damage
62. Primary structure, gene expression and chromosomal mapping of rodent homologs of the MEN1 tumor suppressor gene
63. Structure and distribution of rat menin mRNA
64. Characterization of the mouse Men1 gene and its expression during development
65. Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues
66. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin
67. Characterization of the MEN1 ortholog in zebrafish
68. Isolation, characterization, expression and functional analysis of the zebrafish ortholog of MEN1
69. Complementary DNA structure and genomic organization of drosophila menin
70. Comparative genomics of the eukaryotes
71. Heterogeneity at the 5′-end of MEN1 transcripts
72. Stable overexpression of MEN1 suppresses tumorigenicity of RAS
73. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
74. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism
75. Identification and characterization of JunD missense mutants that lack menin binding
76. Premature centromere division in patients with multiple endocrine neoplasia type 1
77. Chromosomal instability in multiple endocrine neoplasia type 1: Cytogenetic evaluation with DEB test
78. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
79. Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations
80. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory
81. Molecular diagnosis of familial adenomatous polyposis
82. Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization
83. Determination of gene dosage by a quantitative adaptation of the polymerase chain reaction (gd-PCR): Rapid detection of deletions and duplications of gene sequences
84. Burin): Further studies and non-linkage to HLA
85. Prolactinomas in familial multiple endocrine neoplasia syndrome type I. Relationship to HLA and carcinoid tumors
86. Burin) in four kindreds from Newfoundland
87. Familial isolated hyperparathyroidism: A distinct genetic entity with an increased risk of parathyroid cancer
88. Novel V184E MEN1 germline mutation in a Japanese Kindred with familial hyperparathyroidism
89. A novel mutation of the MEN1 gene in a Japanese kindred with familial isolated primary hyperparathyroidism
90. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region
91. Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree
92. Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism
93. A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors
94. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families
95. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: A clinically and genetically distinct syndrome
96. Hereditary hyperparathyroidism-jaw tumor syndrome: The endocrine tumor gene HRPT2 maps to chromosome 1q21-q31
97. Familial acromegaly: A specific clinical entity - Further evidence from the genetic study of a three-generation family
98. Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene
99. A newly recognized germline mutation of MEN1 gene identified in a patient with parathyroid adenoma and carcinoma
100. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation
101. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13
102. A suggested nomenclature for designating mutations
103. Acromegaly in a family without a mutation in the menin gene
104. Analysis of recurrent germline mutations in the MEN1 gene encountered in apparently unrelated families
105. 11q13 allelotype analysis in 27 Northern American MEN1 kindreds identifies two distinct founder chromosomes
106. Splicing of messenger RNA precursors
107. A 5178-9G→ A splice donor site mutation in intron 4 of the men1 gene causing multiple endocrine neoplasia type 1